BENDAMUSTINE IN COMBINATION WITH RITUXIMAB AS FIRST LINE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE REAL PRACTICE ITALIAN MULTICENTRE STUDY

被引：0
|
作者：
Gentile, M. [1 ]
Ciolli, S. [2 ]
Molica, S. [3 ]
Di Renzo, N. [4 ]
Selleri, C. [5 ]
Villa, M. R. [6 ]
De Paolis, M. R. [4 ]
Scortechini, I. [7 ]
Giannotta, A. [8 ]
Minoia, C. [9 ]
Boncompagni, R. [2 ]
Bonanno, V. [10 ]
Levato, L. [3 ]
Musso, M. [10 ]
Mastrullo, L. [6 ]
Melpignano, A. [8 ]
Murru, R. [11 ]
Angelucci, E. [11 ]
Caparrotti, G. [1 ,2 ,12 ]
Guarini, A. [1 ,3 ,13 ]
Pinto, A. [1 ,4 ,14 ]
Ferrara, F. [1 ,5 ,15 ]
Zinzani, P. [1 ,6 ,16 ]
Morabito, F. [1 ,7 ,17 ]
机构：
[1] UOC Ematol Cosenza, Cosenza, Italy
[2] Azienda Osped Univ Careggi, SODC Ematol, Florence, Italy
[3] Pugliese Ciaccio Hosp, Dept Oncol & Haematol, Catanzaro, Italy
[4] Osped Vito Fazzi, Hematol Unit, Lecce, Italy
[5] Univ Salerno, Hematol & SCT Transplant Ctr, Dept Med, AOU San Giovanni Dio & Ruggi Aragona, I-84100 Salerno, Italy
[6] UOC Ematol PO San Gennaro Napoli, Naples, Italy
[7] AO Osped Riuniti Marche, Div Ematol, Ancona, Italy
[8] Osped Antonio Perrino Brindisi, UOC Ematol, Brindisi, Italy
[9] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[10] UO Ematol & Trapianto Midollo Osseo La Maddalena, Palermo, Italy
[11] A Businco Cagliari, UO Ematol Osped Oncol, Cagliari, Italy
[12] PO G Moscati Aversa, UO Ematol, Aversa, Italy
[13] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[14] IRCCS Fdn G Pascale Napoli, SC Ematol Oncol INT, Naples, Italy
[15] Osped Cardarelli Napoli, Div Ematol, Naples, Italy
[16] L&A Seragnoli Bologna, Inst Hematol & Med Oncol, Bologna, Italy
[17] UOC Ematol Cosenza, Cosenza, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1503
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [1] Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study
    Gentile, Massimo
    Ciolli, Stefania
    Molica, Stefano
    Di Renzo, Nicola
    Selleri, Carmine
    Villa, Maria Rosaria
    De Paolis, Maria Rosaria
    Scortechini, Ilaria
    Giannotta, Angela
    Minoia, Carla
    Rago, Angela
    Boncompagni, Riccardo
    Bonanno, Vincenza
    Levato, Luciano
    Musso, Maurizio
    Mastrullo, Lucia
    Melpignano, Angela
    Murru, Roberta
    Angelucci, Emanuele
    Tarantini, Giuseppe
    Caparrotti, Giuseppe
    Guarini, Attilio
    Ferrara, Felicetto
    Cimino, Giuseppe
    Zinzani, Pier Luigi
    Morabito, Fortunato
    BLOOD, 2014, 124 (21)
  • [2] BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY
    Iannitto, E.
    Morabito, F.
    Mancuso, S.
    Gentile, M.
    Augello, A.
    Bongarzoni, V.
    Cascavilla, N.
    D'Arco, A.
    Di Renzo, N.
    Fazzi, R.
    Ferrara, F.
    Franco, G.
    Gobbi, M.
    Liardo, E.
    Liberati, A. M.
    Marasca, R.
    Montanini, A.
    Mule, A.
    Musso, M.
    Musto, P.
    Pennese, E.
    Piccin, A.
    Scalabrini, D. Rota
    Sciacca, M.
    Visani, G.
    Abbadessa, V.
    Rigacci, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 323 - 323
  • [3] BENDAMUSTINE AND RITUXIMAB AS FIRST OR SECOND LINE THERAPY IN ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Gozzetti, A.
    Ciolli, S.
    Candi, V.
    Breschi, C.
    Fabbri, A.
    Schiattone, L.
    Cencini, E.
    Papini, G.
    Raspadori, D.
    Defina, M.
    Aprile, L.
    Bosi, A.
    Bocchia, M.
    HAEMATOLOGICA, 2014, 99 : 592 - 592
  • [4] Bendamustine in Combination with Rituximab (BR) for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase II Trial of the German CLL Study Group (GCLLSG)
    Fischer, Kirsten
    Stilgenbauer, Stephan
    Schweighofer, Carmen D.
    Busch, Raymonde
    Renschler, Jasmin
    Kiehl, Michael
    Balleisen, Leopold
    Eckart, Michael J.
    Fink, Anna-Maria
    Kilp, Julia
    Ritgen, Matthias
    Boettcher, Sebastian
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Wendtner, Clemens-Martin
    BLOOD, 2008, 112 (11) : 128 - 128
  • [5] Bendamustine in combination with rituximab (BR) for patients with relapsed chronic lymphocytic leukemia (CLL): A multicentre phase II trail of the German CLL Study Group (GCLLSG).
    Fischer, Kirsien
    Stilgenbauer, Stephan
    Schweighofer, Carmen D.
    Renschler, Jasmin
    Busch, Raymonde
    Kiehl, Michael
    Balleisen, Leopold
    Eckart, Michael
    Fink, Anna M.
    Boettcher, Sebastian
    Ritgen, Matthias
    Kneba, Michael
    Staib, Peter
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    BLOOD, 2007, 110 (11) : 913A - 914A
  • [6] FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RETROSPECTIVE STUDY
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Ionita, M.
    Calamar, D.
    Ionita, C. O.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 526 - 526
  • [7] Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
    Maurer, Christian
    Pflug, Natali
    Bahlo, Jasmin
    Kluth, Sandra
    Rhein, Christina
    Cramer, Paula
    Gross-Ophoff, Carolin
    Langerbeins, Petra
    Fink, Anna-Maria
    Eichhorst, Barbara
    Kreuzer, Karl-Anton
    Fischer, Norbert
    Tausch, Eugen
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Doehner, Hartmut
    Kneba, Michael
    Dreyling, Martin
    Binder, Mascha
    Hallek, Michael
    Wendtner, Clemens-Martin
    Bergmann, Manuela
    Fischer, Kirsten
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (03) : 253 - 260
  • [8] Combination Therapy with Lenalidomide and Rituximab in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)
    Ferrajoli, Alessandra
    Badoux, Xavier C.
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Estrov, Zeev
    Pasia, Manolo
    Lee, Bang-Ning
    Reuben, James M.
    Kantarjian, Hagop
    Keating, Michael
    BLOOD, 2009, 114 (22) : 89 - 90
  • [9] Efficacy of a bendamustine and rituximab combination in first-line therapy for chronic lymphocytic leukemia: Results of the BEN-001 study
    Stadnik, E. A.
    Strugov, V. V.
    Andreeva, T. O.
    Virts, Yu. V.
    Rumyantsev, A. M.
    Mirolyubova, Yu. V.
    Butylin, P. A.
    Zaritsky, A. Yu.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 57 - 64
  • [10] Rituximab as first-line and maintenance therapy for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL).
    Hainsworth, JD
    Litchy, S
    Burris, HA
    Greco, FA
    BLOOD, 2001, 98 (11) : 363A - 363A
12345